New drug ZE50-0134 put to the test in healthy volunteers
NCT ID NCT06787131
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 25 times
Summary
This early-stage study tested a new drug called ZE50-0134 in 104 healthy adults aged 18 to 55. The main goal was to check if the drug is safe and how the body processes it, not to treat any disease. Participants took single or multiple doses of the drug or a placebo, and some also took a stomach acid drug to see if it changed drug levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Scientia Clinical Research
Sydney, Randwick NSW, 2031, Australia
Conditions
Explore the condition pages connected to this study.